BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

861 related articles for article (PubMed ID: 16142737)

  • 21. Treatment of primary Sjögren's syndrome with hydroxychloroquine: a retrospective, open-label study.
    Fox RI; Dixon R; Guarrasi V; Krubel S
    Lupus; 1996 Jun; 5 Suppl 1():S31-6. PubMed ID: 8803908
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Clinicopathological findings consistent with primary Sjögren's syndrome in a subset of patients diagnosed with chronic fatigue syndrome: preliminary observations.
    Sirois DA; Natelson B
    J Rheumatol; 2001 Jan; 28(1):126-31. PubMed ID: 11196514
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Serum sickness induced by rituximab infusion; report of two cases with hematological malignancies].
    Matsui T; Hidaka M; Kawakita T; Inoue Y; Sakai T; Harada N; Takemoto S; Nagakura S; Tsukamoto A; Kiyokawa T; Kawano F
    Rinsho Ketsueki; 2009 Apr; 50(4):304-8. PubMed ID: 19404025
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Persistence of immunoglobulin-producing cells in parotid salivary glands of patients with primary Sjögren's syndrome after B cell depletion therapy.
    Hamza N; Bootsma H; Yuvaraj S; Spijkervet FK; Haacke EA; Pollard RP; Visser A; Vissink A; Kallenberg CG; Kroese FG; Bos NA
    Ann Rheum Dis; 2012 Nov; 71(11):1881-7. PubMed ID: 22615459
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Clinical trial of ambroxol (Mucosolvan) in Sjögren's syndrome.
    Ichikawa Y; Tokunaga M; Shimizu H; Moriuchi J; Takaya M; Arimori S
    Tokai J Exp Clin Med; 1988 Aug; 13(3):165-9. PubMed ID: 2978189
    [TBL] [Abstract][Full Text] [Related]  

  • 26. B cell MALT lymphoma diagnosed by labial minor salivary gland biopsy in patients screened for Sjögren's syndrome.
    Van Mello NM; Pillemer SR; Tak PP; Sankar V
    Ann Rheum Dis; 2005 Mar; 64(3):471-3. PubMed ID: 15708896
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Diminished peripheral blood memory B cells and accumulation of memory B cells in the salivary glands of patients with Sjögren's syndrome.
    Hansen A; Odendahl M; Reiter K; Jacobi AM; Feist E; Scholze J; Burmester GR; Lipsky PE; Dörner T
    Arthritis Rheum; 2002 Aug; 46(8):2160-71. PubMed ID: 12209521
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Gene expression profile in the salivary glands of primary Sjögren's syndrome patients before and after treatment with rituximab.
    Devauchelle-Pensec V; Cagnard N; Pers JO; Youinou P; Saraux A; Chiocchia G
    Arthritis Rheum; 2010 Aug; 62(8):2262-71. PubMed ID: 20506202
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Most cases of primary salivary mucosa-associated lymphoid tissue lymphoma are associated either with Sjoegren syndrome or hepatitis C virus infection.
    Ambrosetti A; Zanotti R; Pattaro C; Lenzi L; Chilosi M; Caramaschi P; Arcaini L; Pasini F; Biasi D; Orlandi E; D'Adda M; Lucioni M; Pizzolo G
    Br J Haematol; 2004 Jul; 126(1):43-9. PubMed ID: 15198730
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Sjögren's syndrome associated with systemic lupus erythematosus: clinical and laboratory profiles and comparison with primary Sjögren's syndrome.
    Manoussakis MN; Georgopoulou C; Zintzaras E; Spyropoulou M; Stavropoulou A; Skopouli FN; Moutsopoulos HM
    Arthritis Rheum; 2004 Mar; 50(3):882-91. PubMed ID: 15022331
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Adult heart block is associated with disease activity in primary Sjögren's syndrome.
    Lodde BM; Sankar V; Kok MR; Leakan RA; Tak PP; Pillemer SR
    Scand J Rheumatol; 2005; 34(5):383-6. PubMed ID: 16234186
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Etanercept in the treatment of patients with primary Sjögren's syndrome: a pilot study.
    Zandbelt MM; de Wilde P; van Damme P; Hoyng CB; van de Putte L; van den Hoogen F
    J Rheumatol; 2004 Jan; 31(1):96-101. PubMed ID: 14705226
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Cryoglobulinaemia related to Sjogren's syndrome or HCV infection: differences based on the pattern of bone marrow involvement, lymphoma evolution and laboratory tests after parotidectomy.
    De Vita S; Quartuccio L; Salvin S; Corazza L; Zabotti A; Fabris M
    Rheumatology (Oxford); 2012 Apr; 51(4):627-33. PubMed ID: 22210656
    [TBL] [Abstract][Full Text] [Related]  

  • 34. True primary Sjögren's syndrome in a subset of patients with hepatitis C infection: a model linking chronic infection to chronic sialadenitis.
    De Vita S; Damato R; De Marchi G; Sacco S; Ferraccioli G
    Isr Med Assoc J; 2002 Dec; 4(12):1101-5. PubMed ID: 12516900
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Exocrine function in primary Sjögren syndrome: natural course and prognostic factors.
    Haldorsen K; Moen K; Jacobsen H; Jonsson R; Brun JG
    Ann Rheum Dis; 2008 Jul; 67(7):949-54. PubMed ID: 17962240
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Rates of infiltration by macrophages and dendritic cells and expression of interleukin-18 and interleukin-12 in the chronic inflammatory lesions of Sjögren's syndrome: correlation with certain features of immune hyperactivity and factors associated with high risk of lymphoma development.
    Manoussakis MN; Boiu S; Korkolopoulou P; Kapsogeorgou EK; Kavantzas N; Ziakas P; Patsouris E; Moutsopoulos HM
    Arthritis Rheum; 2007 Dec; 56(12):3977-88. PubMed ID: 18050195
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Etanercept in Sjögren's syndrome: a twelve-week randomized, double-blind, placebo-controlled pilot clinical trial.
    Sankar V; Brennan MT; Kok MR; Leakan RA; Smith JA; Manny J; Baum BJ; Pillemer SR
    Arthritis Rheum; 2004 Jul; 50(7):2240-5. PubMed ID: 15248223
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Brief Report: Ultrasonographic Assessment of Salivary Gland Response to Rituximab in Primary Sjögren's Syndrome.
    Jousse-Joulin S; Devauchelle-Pensec V; Cornec D; Marhadour T; Bressollette L; Gestin S; Pers JO; Nowak E; Saraux A
    Arthritis Rheumatol; 2015 Jun; 67(6):1623-8. PubMed ID: 25708147
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Pure sensory neuropathy in primary Sjögren's syndrome. Longterm prospective followup and review of the literature.
    Font J; Ramos-Casals M; de la Red G; Pou A; Casanova A; García-Carrasco M; Cervera R; Molina JA; Valls J; Bové A; Ingelmo M; Graus F
    J Rheumatol; 2003 Jul; 30(7):1552-7. PubMed ID: 12858457
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Proposed core set of outcome measures in patients with primary Sjögren's syndrome: 5 year follow up.
    Theander E; Andersson SI; Manthorpe R; Jacobsson LT
    J Rheumatol; 2005 Aug; 32(8):1495-502. PubMed ID: 16078325
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 44.